Copyright
©The Author(s) 2015.
World J Gastroenterol. Mar 21, 2015; 21(11): 3308-3316
Published online Mar 21, 2015. doi: 10.3748/wjg.v21.i11.3308
Published online Mar 21, 2015. doi: 10.3748/wjg.v21.i11.3308
Table 4 Univariate analysis of risk factors for active tuberculosis infection after anti-TNF therapy n (%)
| TB infection + (n = 16) | TB infection - (n = 360) | P value | |
| Age at anti-TNF (yr) | 26 (21-70) | 30 (11-76) | 0.808 |
| Female | 3 (18.8) | 118 (32.8) | 0.287 |
| Diseases | 0.772 | ||
| Crohn’s disease | 11 (68.8) | 266 (73.9) | |
| Ulcerative colitis | 5 (31.3) | 94 (26.1) | |
| Diabetes mellitus | 1 (6.3) | 11 (3.1) | 0.411 |
| Anti-TNF agent | 0.212 | ||
| Infliximab | 15 (93.8) | 279 (77.5) | |
| Adalimumab | 1 (6.3) | 81 (22.5) | |
| LTBI | 4 (25) | 26 (7.2) | 0.031 |
| IM at anti-TNF agent | 13 (81.3) | 228 (63.3) | 0.187 |
| WBC count < 5000 mm3 | 10 (62.5) | 115 (31.9) | 0.015 |
- Citation: Kim ES, Song GA, Cho KB, Park KS, Kim KO, Jang BI, Kim EY, Jeon SW, Lee HS, Yang CH, Lee YK, Lee DW, Kim SK, Kim TO, Lee J, Kim HW, Jee SR, Park SJ, Kim HJ. Significant risk and associated factors of active tuberculosis infection in Korean patients with inflammatory bowel disease using anti-TNF agents. World J Gastroenterol 2015; 21(11): 3308-3316
- URL: https://www.wjgnet.com/1007-9327/full/v21/i11/3308.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i11.3308